Immunomodulation characteristics by thermal ablation therapy in cancer patients

ConclusionsWe suggest a further immunomodulation therapy after thermal therapy for recovering a Th1‐ and Tc1‐dominant immune response for pursuing a better long‐term antitumor immunity.

Source: Asia-Pacific Journal of Clinical Oncology - December 1, 2017 Category: Cancer & Oncology Authors: Wuwei Yang, Wei Wang, Bing Liu, Baorang Zhu, Jing Li, Debao Xu, Yanli Ni, Li Bai, Guangxian Liu Tags: ORIGINAL ARTICLE Source Type: research